Founded in 2010, Dr. Agarwal's Health Care Limited is a leading provider of specialized eye care services. The IPO for Dr. Agarwal’s Healthcare was open for bidding from January 29, 2025, to January 31, 2025.
Dr. Agarwal’s Healthcare has launched its IPO as a book-built issue worth ₹3,027.26 crores. The offering includes a fresh issue of 0.75 crore shares, raising ₹300 crores, along with an offer for the sale of 6.78 crore shares, totalling ₹2,727.26 crores. The price band for the IPO is set between ₹382 and ₹402 per share. Retail investors can participate with a minimum lot size of 35 shares, requiring an investment of ₹14,070. For small non-institutional investors (sNII), the minimum application is 15 lots (525 shares), amounting to ₹2,11,050, while large non-institutional investors (bNII) need to apply for at least 72 lots (2,520 shares), requiring an investment of ₹10,13,040.
Also Read : Dr. Agarwal’s Healthcare IPO Day 1 Subscription Status ,Dr. Agarwal’s Healthcare IPO Day 2 Subscription Status,Dr. Agarwal’s Healthcare IPO Day 3 Subscription Status
The company intends to utilize the net proceeds from the fresh issue for the following purposes:
Dr. Agarwal’s Healthcare IPO was subscribed 1.49 times overall. The public issue saw a subscription of 0.42 times in the retail category, 4.41 times in the Qualified Institutional Buyers (QIB) segment, and 0.39 times among Non-Institutional Investors (NII). Within the NII category, bids from large investors (bNII) subscribing above ₹10 lakh reached 0.29 times, while small investors (sNII) bidding below ₹10 lakh subscribed 0.54 times. The employee segment recorded a 0.26 times subscription, while other investors subscribed 0.51 times.
On Monday, the grey market premium (GMP) for Dr Agarwal's Health Care unlisted shares witnessed a decline as per Business Standard. The shares were trading at approximately Rs 402.5 per piece, reflecting a marginal GMP of just Rs 0.5 or 0.12% over the upper price band. This is a sharp drop from the Rs 12 premium recorded a day earlier when the IPO opened for subscription.
Dr. Agarwal's Health Care Limited, founded in 2010, is a leading specialized eye care provider in India, offering treatments such as cataract and refractive surgeries, diagnostic consultations, non-surgical procedures, and optical products. By September 30, 2024, the company had 737 doctors and had treated 2.13 million patients, performing 220,523 surgeries. In the preceding six months, it served 1.15 million patients and conducted 140,787 surgeries. Operating through a hub-and-spoke model, its Indian network included 28 hubs (three Centers of Excellence) and 165 spoke facilities across 117 cities in 14 states and four union territories, totaling 193 eye care centers, solidifying its leadership in ophthalmology.
Disclaimer: The GMP (Grey Market Premium) price is unauthenticated market-related news and has no discernible basis. The same quoted above is as per news that appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade or deal in the grey market, nor do we recommend or endorse trading in the grey market.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.